Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q35000906
A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancerERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapyThe herb medicine formula "chong lou fu fang" increases the cytotoxicity of chemotherapeutic agents and down-regulates the expression of chemotherapeutic agent resistance-related genes in human gastric cancer cells in vitro.Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.High expression levels of class III β-tubulin in resected non-small cell lung cancer patients are predictive of improved patient survival after vinorelbine-based adjuvant chemotherapy.IL-6 and TNF-α promote metastasis of lung cancer by inducing epithelial-mesenchymal transition.Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.[Advances of drug resistance marker of gemcitabine for non-small cell lung cancer].New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials†.New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
P2860

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q35000906
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@ast
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@en
type
label
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@ast
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@en
prefLabel
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@ast
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Pharmacogenomic strategies for ...... in non-small cell lung cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921